Silvia I. Cazorla

2.2k total citations · 1 hit paper
49 papers, 1.7k citations indexed

About

Silvia I. Cazorla is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Silvia I. Cazorla has authored 49 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 24 papers in Public Health, Environmental and Occupational Health and 12 papers in Molecular Biology. Recurrent topics in Silvia I. Cazorla's work include Trypanosoma species research and implications (27 papers), Research on Leishmaniasis Studies (24 papers) and Probiotics and Fermented Foods (7 papers). Silvia I. Cazorla is often cited by papers focused on Trypanosoma species research and implications (27 papers), Research on Leishmaniasis Studies (24 papers) and Probiotics and Fermented Foods (7 papers). Silvia I. Cazorla collaborates with scholars based in Argentina, Germany and Spain. Silvia I. Cazorla's co-authors include Gabriela Perdigón, Emilio L. Malchiodi, Carolina Maldonado Galdeano, Eva María del Mar Vélez, Fernanda M. Frank, Carlos A. Guzmán, Valeria P. Sülsen, Virginia S. Martino, Ricardo S. Corral and Augusto E. Bivona and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Clinical Microbiology.

In The Last Decade

Silvia I. Cazorla

46 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Beneficial Effects of Probiotic Consumption on the Immune System

2019 495 citations Carolina Maldonado Galdeano, Silvia I. Cazorla et al. profile →

Peers

Silvia I. Cazorla

EPIDE

PHEOH

PARAS

Cláudio Vieira da Silva Brazil

Flávia Raquel Fernandes do Nascimento Brazil

Andrew J. Nok Nigeria

Angela H. Lopes Brazil

Anil Kumar Gupta India

Lucy Megumi Yamauchi Brazil

Ivete Conchon‐Costa Brazil

Marcos José Marques Brazil

Kátia da Silva Calabrese Brazil

Gilson Costa Macedo Brazil

Cláudio Vieira da Silva Brazil

Silvia I. Cazorla

549 ×0.8

EPIDE

375 ×0.7

457 ×0.8

PHEOH

156 ×0.4

277 ×1.2

PARAS

Citations per year, relative to Silvia I. Cazorla Silvia I. Cazorla (= 1×) peers Cláudio Vieira da Silva

Countries citing papers authored by Silvia I. Cazorla

Since Specialization

Citations

This map shows the geographic impact of Silvia I. Cazorla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia I. Cazorla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia I. Cazorla more than expected).

Fields of papers citing papers by Silvia I. Cazorla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia I. Cazorla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia I. Cazorla. The network helps show where Silvia I. Cazorla may publish in the future.

Co-authorship network of co-authors of Silvia I. Cazorla

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia I. Cazorla. A scholar is included among the top collaborators of Silvia I. Cazorla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia I. Cazorla. Silvia I. Cazorla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cazorla, Silvia I., et al.. (2025). Probiotic–intestinal epithelium crosstalk: mechanisms of adhesion, signalling, and immunomodulation. International Journal of Food Sciences and Nutrition. 76(8). 784–797.

Rodríguez, María Cecilia, Christina Lopez, Silvia I. Cazorla, et al.. (2024). Lacticaseibacillus rhamnosus CRL 2244 secreted metabolites display killing and antibiotic synergistic activity against multi-drug resistant pathogens. PLoS ONE. 19(6). e0306273–e0306273. 1 indexed citations

Bontempi, Esteban J., et al.. (2023). Antiprotozoal compounds from Mikania periplocifolia (Asteraceae). Fitoterapia. 167. 105499–105499. 1 indexed citations

Perdigón, Gabriela, et al.. (2023). Evaluation of Rouxiella badensis Subsp Acadiensis (Canan SV-53) as a Potential Probiotic Bacterium. Microorganisms. 11(5). 1347–1347. 6 indexed citations

Monteros, María J., Carolina Maldonado Galdeano, R Weill, et al.. (2021). Probiotic lactobacilli as a promising strategy to ameliorate disorders associated with intestinal inflammation induced by a non-steroidal anti-inflammatory drug. Scientific Reports. 11(1). 571–571. 35 indexed citations

Alberti, Andrés Sánchez, Augusto E. Bivona, Natacha Cerny, et al.. (2020). Mucosal Heterologous Prime/Boost Vaccination Induces Polyfunctional Systemic Immunity, Improving Protection Against Trypanosoma cruzi. Frontiers in Immunology. 11. 128–128. 25 indexed citations

Cerny, Natacha, Augusto E. Bivona, Andrés Sánchez Alberti, et al.. (2020). Cruzipain and Its Physiological Inhibitor, Chagasin, as a DNA-Based Therapeutic Vaccine Against Trypanosoma cruzi. Frontiers in Immunology. 11. 565142–565142. 11 indexed citations

Bivona, Augusto E., Andrés Sánchez Alberti, Natacha Cerny, et al.. (2018). Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine. PLoS neglected tropical diseases. 12(3). e0006384–e0006384. 26 indexed citations

Cazorla, Silvia I., et al.. (2017). Immunization with Tc52 or its amino terminal domain adjuvanted with c-di-AMP induces Th17+Th1 specific immune responses and confers protection against Trypanosoma cruzi. PLoS neglected tropical diseases. 11(2). e0005300–e0005300. 37 indexed citations

10.

Cerny, Natacha, Augusto E. Bivona, Andrés Sánchez Alberti, et al.. (2017). Assessment of sesquiterpene lactones isolated from Mikania plants species for their potential efficacy against Trypanosoma cruzi and Leishmania sp.. PLoS neglected tropical diseases. 11(9). e0005929–e0005929. 33 indexed citations

11.

Alberti, Andrés Sánchez, et al.. (2016). A prime-boost immunization with Tc52 N-terminal domain DNA and the recombinant protein expressed in Pichia pastoris protects against Trypanosoma cruzi infection. Vaccine. 34(28). 3243–3251. 19 indexed citations

12.

Cazorla, Silvia I., Natacha Cerny, Andrés Sánchez Alberti, et al.. (2014). Oral Multicomponent DNA Vaccine Delivered by Attenuated Salmonella Elicited Immunoprotection Against American Trypanosomiasis. The Journal of Infectious Diseases. 211(5). 698–707. 29 indexed citations

13.

Fabian, Lacramioara, Valeria P. Sülsen, Fernanda M. Frank, et al.. (2013). In Silico Study of Structural and Geometrical Requirements of Natural Sesquiterpene Lactones with Trypanocidal Activity. Mini-Reviews in Medicinal Chemistry. 13(10). 1407–1414. 13 indexed citations

14.

Ponce, Nicolás Eric, Eugenio Antonio Carrera Silva, Andrea Pellegrini, et al.. (2012). Trypanosoma cruzi, the causative agent of Chagas disease, modulates interleukin-6-induced STAT3 phosphorylation via gp130 cleavage in different host cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1832(3). 485–494. 18 indexed citations

15.

Frank, Fernanda M., Valeria P. Sülsen, Silvia I. Cazorla, et al.. (2011). South American medicinal flora: a promising source of novel compounds with antiprotozoal activity. Latin American Journal of Pharmacy. 3 indexed citations

16.

Sülsen, Valeria P., Fernanda M. Frank, Silvia I. Cazorla, et al.. (2011). Psilostachyin C: a natural compound with trypanocidal activity. International Journal of Antimicrobial Agents. 37(6). 536–543. 39 indexed citations

17.

Cazorla, Silvia I., Fernanda M. Frank, Gabriela L. Borosky, et al.. (2011). Synthesis, trypanocidal activity and molecular modeling studies of 2-alkylaminomethylquinoline derivatives. European Journal of Medicinal Chemistry. 46(9). 3696–3703. 28 indexed citations

18.

Cazorla, Silvia I., Fernanda M. Frank, Pablo D. Becker, et al.. (2010). Redirection of the Immune Response to the Functional Catalytic Domain of the Cystein Proteinase Cruzipain Improves Protective Immunity againstTrypanosomacruziInfection. The Journal of Infectious Diseases. 202(1). 136–144. 41 indexed citations

19.

Andreani, Guadalupe, et al.. (2009). Inhibition of HIV-1 Replication in Human Monocyte-Derived Macrophages by Parasite Trypanosoma cruzi. PLoS ONE. 4(12). e8246–e8246. 9 indexed citations

20.

Frank, Fernanda M., Silvia I. Cazorla, M.J. Sartori, & Ricardo S. Corral. (2007). Elicitation of specific, Th1-biased immune response precludes skeletal muscle damage in cruzipain-vaccinated mice. Experimental and Molecular Pathology. 84(1). 64–70. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact